COMPANY PROFILE // THE 014 REPORT
ClearPoint Neuro, Inc.
CLPT (Nasdaq) · Formerly: MRI INTERVENTIONS, INC.; SURGIVISION INC; SURGI VISION INC
Assembled from 3 government sources in 3.0 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- InfoUSAspending recipient D777WG1K5PL4 (matched to this company by exact name) has no entity registration in the SAM.gov public extract of 2026-11-01.possible match
✓ SEC filings✓ SAM registrationpossible match✗ LEI✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no IRS return, no state registration, no website, no lobbying registration on record.
ClearPoint Neuro, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in DE, based in Solana Beach, CA; listed as CLPT (Nasdaq).[source] It reported revenue of $37.0 million for the fiscal year ended 2025-12-31.[source] It has filed 104 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-18.[source] Its largest institutional holders on 13F filings are BlackRock, Inc., MAK CAPITAL ONE LLC, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info1
- BlackRock, Inc.$42.5M
- MAK CAPITAL ONE LLC$42.4M
- VANGUARD CAPITAL MANAGEMENT LLC$22.0M
- STATE STREET CORP$14.6M
- GEODE CAPITAL MANAGEMENT, LLC$13.4M
- Lane Generational LLC$7.9M
- UBS Group AG$7.6M
- MILLENNIUM MANAGEMENT LLC$6.4M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- BURNETT JOSEPH · CEO and President (Director,Officer) · latest Form 4 2026-03-20 · filing · LinkedIn search
- D'Alessandro Danilo · Chief Financial Officer (Officer) · latest Form 4 2026-03-16 · filing · LinkedIn search
- SABRA MAZIN · Chief Operating Officer (Officer) · latest Form 4 2026-03-16 · filing · LinkedIn search
- STIGALL L. JEREMY · Chief Business Officer (Officer) · latest Form 4 2026-03-16 · filing · LinkedIn search
- FALLON LYNNETTE C · Director · latest Form 4 2025-06-05 · filing · LinkedIn search
- FLETCHER R JOHN · Director · latest Form 4 2026-01-05 · filing · LinkedIn search
- Girin Pascal E R · Director · latest Form 4 2026-01-05 · filing · LinkedIn search
- JOHNSON B KRISTINE · Director · latest Form 4 2025-05-23 · filing · LinkedIn search
- Klein Matthew B. · Director · latest Form 4 2025-05-23 · filing · LinkedIn search
- LIAU LINDA M. · Director · latest Form 4 2025-05-23 · filing · LinkedIn search
- Richards Timothy T. · Director · latest Form 4 2026-01-05 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001285550 | source |
| UEIpossible match | D777WG1K5PL4 | source |
| UEIpossible match | YRFSE7QUB6Q7 | source |
| CAGEpossible match | 9ALE0 | source |
| EIN | 58-2394628 | source |
| Business address (SEC) | 120 S. SIERRA AVENUE, SOLANA BEACH, CA, 92075 | source |
Does not exist in the records we hold: LEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2026-12-02 · in 12 days · SAM registration expires (UEI YRFSE7QUB6Q7)possible match
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
ADDRESS · ZIP CODE
Location context
At the same address (2)
- BRUTTEN FAMILY FOUNDATION · IRS-registered organization
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- KORU Medical Systems, Inc. · FLETCHER R JOHN
- AtriCure, Inc. · JOHNSON B KRISTINE
- PTC THERAPEUTICS, INC. · Klein Matthew B.
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-12-02 registration SAM registration expiry (UEI YRFSE7QUB6Q7) · SAM.gov
- 2026-11-18 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2026-11-18 filing S-3 · SEC EDGAR
- 2026-10-28 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-10-28 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-08-03 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-03 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-06-29 filing 144 · SEC EDGAR
- 2026-06-17 filing 144 · SEC EDGAR
- 2026-06-17 filing 144 · SEC EDGAR
- 2026-06-01 filing 144 · SEC EDGAR
- 2026-05-29 filing 144 · SEC EDGAR
- 2026-05-21 officer change 8-K items 5.02,5.07,9.01 · SEC EDGAR
- 2026-05-21 filing 144 · SEC EDGAR
- 2026-05-20 filing S-8 · SEC EDGAR
- 2026-05-20 filing 144 · SEC EDGAR
- 2026-05-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-13 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-04-23 filing ARS · SEC EDGAR
- 2026-04-23 filing DEFA14A · SEC EDGAR
- 2026-04-10 filing Proxy statement · SEC EDGAR
- 2026-03-17 filing Annual report (10-K) · SEC EDGAR
- 2026-03-17 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-02-25 filing 144 · SEC EDGAR
- 2026-02-20 filing 144/A · SEC EDGAR
- 2026-02-09 filing S-8 · SEC EDGAR
- 2026-02-05 filing 8-K/A items 9.01 · SEC EDGAR
- 2026-02-05 filing D · SEC EDGAR
- 2026-01-27 filing UPLOAD · SEC EDGAR
- 2026-01-26 filing 144 · SEC EDGAR
108 earlier entries
- 2026-01-22 filing EFFECT
- 2026-01-22 filing 424B3
- 2026-01-20 filing CORRESP
- 2026-01-14 filing S-3
- 2026-01-12 filing 8-K items 2.02,9.01
- 2026-01-09 filing 144
- 2026-01-05 filing 8-K items 1.01,2.03
- 2025-11-20 filing 8-K items 1.01,2.01,3.02,7.01,9.01
- 2025-11-12 filing 144
- 2025-11-06 filing Quarterly report (10-Q)
- 2025-11-06 filing 8-K items 2.02,7.01,9.01
- 2025-11-06 filing 8-K items 1.01,7.01,9.01
- 2025-10-10 filing 144
- 2025-09-04 filing S-8
- 2025-08-12 filing Quarterly report (10-Q)
- 2025-08-12 filing 8-K items 2.02,7.01,9.01
- 2025-07-02 insider First Form 3/4/5 on record for SABRA MAZIN (Chief Operating Officer)
- 2025-06-17 filing 8-K items 1.01,9.01
- 2025-06-12 insider First Form 3/4/5 on record for D'Alessandro Danilo (Chief Financial Officer)
- 2025-06-12 insider First Form 3/4/5 on record for STIGALL L. JEREMY (Chief Business Officer)
- 2025-06-11 insider First Form 3/4/5 on record for BURNETT JOSEPH (CEO and President)
- 2025-06-10 filing 144
- 2025-06-09 filing 144
- 2025-06-03 filing 144
- 2025-05-23 officer change 8-K items 5.02,5.07,9.01
- 2025-05-19 filing 8-K items 8.01,9.01
- 2025-05-19 insider First Form 3/4/5 on record for FALLON LYNNETTE C (Director)
- 2025-05-19 insider First Form 3/4/5 on record for JOHNSON B KRISTINE (Director)
- 2025-05-19 insider First Form 3/4/5 on record for Klein Matthew B. (Director)
- 2025-05-19 insider First Form 3/4/5 on record for LIAU LINDA M. (Director)
- 2025-05-13 filing Quarterly report (10-Q)
- 2025-05-13 filing 8-K items 2.02,7.01,9.01
- 2025-05-12 filing 424B5
- 2025-05-12 filing 8-K items 1.01,8.01,9.01
- 2025-04-09 filing Proxy statement
- 2025-04-02 insider First Form 3/4/5 on record for FLETCHER R JOHN (Director)
- 2025-04-02 insider First Form 3/4/5 on record for Girin Pascal E R (Director)
- 2025-04-02 insider First Form 3/4/5 on record for Richards Timothy T. (Director)
- 2025-02-26 filing Annual report (10-K)
- 2025-02-26 filing 8-K items 2.02,7.01,9.01
- 2024-11-07 filing 8-K items 1.01,9.01
- 2024-11-07 filing 424B5
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-11-07 filing 8-K items 2.02,7.01,9.01
- 2024-08-27 filing SC 13D/A
- 2024-08-26 filing 8-K items 7.01,9.01
- 2024-08-07 filing Quarterly report (10-Q)
- 2024-08-07 filing 8-K items 2.02,7.01,9.01
- 2024-05-16 filing S-8
- 2024-05-16 officer change 8-K items 5.02,5.07,9.01
- 2024-05-07 filing Quarterly report (10-Q)
- 2024-05-07 filing 8-K items 2.02,7.01,9.01
- 2024-04-05 filing Proxy statement
- 2024-03-12 filing Annual report (10-K)
- 2024-03-12 filing 8-K items 2.02,7.01,9.01
- 2024-03-01 filing 8-K items 1.01,9.01
- 2024-03-01 filing 424B2
- 2024-02-28 filing 424B5
- 2024-01-08 filing 8-K items 2.02,7.01,9.01
- 2023-11-20 filing EFFECT
- 2023-11-17 filing CORRESP
- 2023-11-16 filing UPLOAD
- 2023-11-09 filing S-3
- 2023-11-09 filing Quarterly report (10-Q)
- 2023-11-09 filing 8-K items 2.02,7.01,9.01
- 2023-08-08 filing Quarterly report (10-Q)
- 2023-08-08 filing 8-K items 2.02,7.01,9.01
- 2023-08-01 filing 8-K items 1.01,9.01
- 2023-06-15 filing SC 13D/A
- 2023-06-05 filing 144
- 2023-05-25 filing 8-K items 5.03,5.07,9.01
- 2023-05-22 filing 8-K items 8.01,9.01
- 2023-05-11 filing Quarterly report (10-Q)
- 2023-05-11 filing 8-K items 2.02,7.01,9.01
- 2023-04-14 filing Proxy statement
- 2023-04-03 filing PRE 14A
- 2023-03-03 officer change 8-K items 1.01,5.02,9.01
- 2023-03-01 filing Annual report (10-K)
- 2023-03-01 filing 8-K items 2.02,9.01
- 2023-01-11 filing 8-K items 2.02,7.01,9.01
- 2022-12-14 filing 8-K items 5.03,9.01
- 2022-11-08 filing Quarterly report (10-Q)
- 2022-11-08 filing 8-K items 2.02,7.01,9.01
- 2022-11-07 filing 8-K items 1.01,9.01
- 2022-09-20 officer change 8-K items 5.02,7.01,9.01
- 2022-08-10 filing Quarterly report (10-Q)
- 2022-08-09 filing 8-K items 2.02,7.01,9.01
- 2022-06-06 filing 8-K items 8.01,9.01
- 2022-06-01 filing S-8
- 2022-05-26 filing 8-K items 5.03,5.07,9.01
- 2022-05-23 filing 8-K items 8.01,9.01
- 2022-05-19 filing 8-K items 3.01
- 2022-05-11 filing Quarterly report (10-Q)
- 2022-05-11 filing 8-K items 2.02,7.01,9.01
- 2022-04-11 filing Proxy statement
- 2022-04-01 filing PRE 14A
- 2022-03-09 filing Annual report (10-K)
- 2022-03-01 filing 8-K items 2.02,9.01
- 2022-02-15 filing 8-K items 2.02,7.01,9.01
- 2022-02-14 filing 8-K items 2.02,7.01,9.01
- 2021-12-17 filing 8-K items 5.03,9.01
- 2021-12-15 filing CT ORDER
- 2021-11-10 filing Quarterly report (10-Q)
- 2021-11-09 filing 8-K items 2.02,7.01,9.01
- 2021-11-02 officer change 8-K items 5.02,7.01,9.01
- 2020-02-11 name change Name changed from MRI INTERVENTIONS, INC.
- 2010-10-22 name change Name changed from SURGIVISION INC
- 2007-05-02 name change Name changed from SURGI VISION INC
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-18 (within 7 days) 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-11-18 (within 7 days) S-3 filed (REGISTRATION STATEMENT)
- 2026-10-28 (within 30 days) 10-Q filed
- 2026-10-28 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-03 (older) 10-Q filed
- 2026-08-03 (older) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-28 (older) earliest certified decision date in the file
- 2026-05-28 (older) latest certified decision date in the file
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-21; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:CLPT The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above; 6 records under a former name, shown apart.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1285550 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | CLPT / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 582394628 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001285550 | SEC EDGAR / IRS |
| CUSIP | 18507C103 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001285550 | SEC EDGAR |
former name (shown apart, not merged) (6)
- former nameMRI Interventions, Inc. · ClinicalTrials.gov
- former nameSurgi-Vision Inc · ClinicalTrials.gov
- former nameMRI INTERVENTIONS, INC. · State licences
- former nameMRI INTERVENTIONS, INC. · State licences
- former nameMRI INTERVENTIONS, INC. · State licences
- former nameMRI INTERVENTIONS INC · EPA ECHO facilities
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $36,971,000 | 2025-12-31 | 10-K, XBRL Revenues | as filed | 2026-11-21 00:44 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$25,540,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-21 00:44 UTC | Report an error |
| Total assets (at 2025-12-31) | $97,747,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-21 00:44 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $28,020,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-21 00:44 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $45,923,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-21 00:44 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-21 00:44 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-21 00:44 UTC | Report an error |
| State of incorporation | DE | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-21 00:44 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-21 00:44 UTC | Report an error |
| Business address | 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CA, 92075 | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-21 00:44 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-21 00:44 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$23,925,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-21 00:44 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $522,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-21 00:44 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $49,077,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-21 00:44 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $9,155,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-21 00:44 UTC | Report an error |
| Form D total offering amount (D filed 2026-02-05) | $17,892,698 | 2026-02-05 | D | as filed | 2026-11-21 00:44 UTC | Report an error |
| Form D total amount sold (D filed 2026-02-05) | $17,892,698 | 2026-02-05 | D | as filed | 2026-11-21 00:44 UTC | Report an error |
| Form D industry group | Biotechnology | 2026-02-05 | D | as filed | 2026-11-21 00:44 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2026-02-05 | D | as filed | 2026-11-21 00:44 UTC | Report an error |
| Form D date of first sale | 2025-11-20 | 2026-02-05 | D | as filed | 2026-11-21 00:44 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-28 · accession 0001193125-26-436412
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $12,075,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Net income (loss) | -$7,460,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Interest expense | $1,446,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Cash and cash equivalents | $46,184,000 | at 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Contract liabilities (total) | $1,978,000 | at 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Contract liabilities, current | $1,550,000 | at 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Contract liabilities, noncurrent | $428,000 | at 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
| Debt due after year 5 | $52,517,000 | at 2026-09-30 | 10-Q | 2026-10-28 | 0001193125-26-436412 | 2026-11-21 00:44 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-18 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-11-18 Filing S-3 filed (REGISTRATION STATEMENT)
- 2026-10-28 Filing 10-Q filed
- 2026-10-28 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-03 Filing 10-Q filed
- 2026-08-03 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-28 Record earliest certified decision date in the file
- 2026-05-28 Record latest certified decision date in the file
- 2026-05-21 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-05-20 Filing S-8 filed
- 2026-05-13 Filing 10-Q filed
- 2026-05-13 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-04-23 Filing ARS filed
- 2026-04-23 Filing DEFA14A filed
- 2026-04-10 Filing DEF 14A filed
- 2026-03-17 Filing 10-K filed
- 2026-03-17 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-02-09 Filing S-8 filed
- 2026-02-05 Filing 8-K/A filed: Item 9.01 exhibits
- 2026-02-05 Filing D filed
- 2026-01-27 Filing UPLOAD filed
- 2026-01-22 Filing EFFECT filed
- 2026-01-22 Filing 424B3 filed (PROSPECTUS)
- 2026-01-20 Filing CORRESP filed
- 2026-01-14 Filing S-3 filed (REGISTRATION STATEMENT)
2 earlier entries
- 2026-01-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-05 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation
8-K item text, as filed (excerpts)
- 2026-11-18 8-K Item 1.01, Entry into a Material Definitive Agreement
In November 2024, ClearPoint Neuro, Inc. (the “Company”) entered into an At-The-Market Equity Offering Sales Agreement (the “Original Sales Agreement”) with Stifel, Nicolaus & Company, Incorporated, as sales agent (the “Agent”), to sell shares of the Company’s common stock having aggregate sales proceeds of up to $50 million (the “Shares”), from time to time, through an “at the market offering” program, as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the “Securities Act”). On November 18, 2026, the Company and the Agent entered into an amendment to the Original Sales Agreement (the “Sales Agreement Amendment,” and collectively with the Original Sales Agreement… the 8-K · retrieved 2026-11-21 00:44 UTC - 2026-10-28 8-K Item 2.02, Results of Operations and Financial Condition
On October 28, 2026, ClearPoint Neuro, Inc. (the “Company”) issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1. The information in Item 2.02 of this Form 8-K, as well as Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. the 8-K · retrieved 2026-11-21 00:44 UTC - 2026-10-28 8-K Item 7.01, Regulation FD Disclosure
On October 28, 2026, the Company posted an updated investor presentation to its website at https://ir.clearpointneuro.com/news-events/presentations. A copy of the investor presentation is being furnished herewith as Exhibit 99.2. The Company may use the investor presentation from time to time in conversations with analysts, investors and others. The information in Item 7.01 of this Form 8-K, as well as Exhibit 99.2 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. the 8-K · retrieved 2026-11-21 00:44 UTC - 2026-08-03 8-K Item 2.02, Results of Operations and Financial Condition
On August 3, 2026, ClearPoint Neuro, Inc. (the “Company”) issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1. The information in Item 2.02 of this Form 8-K, as well as Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. the 8-K · retrieved 2026-11-21 00:44 UTC - 2026-08-03 8-K Item 7.01, Regulation FD Disclosure
On August 3, 2026, the Company posted an updated investor presentation to its website at https://ir.clearpointneuro.com/news-events/presentations. A copy of the investor presentation is being furnished herewith as Exhibit 99.2. The Company may use the investor presentation from time to time in conversations with analysts, investors and others. The information in Item 7.01 of this Form 8-K, as well as Exhibit 99.2 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. the 8-K · retrieved 2026-11-21 00:44 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $42,455,704 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 2 | MAK CAPITAL ONE LLC | $42,385,360 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $21,993,277 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 4 | STATE STREET CORP | $14,567,198 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $13,382,449 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 6 | Lane Generational LLC | $7,935,785 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 7 | UBS Group AG | $7,646,795 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 8 | MILLENNIUM MANAGEMENT LLC | $6,380,940 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 9 | BROWN ADVISORY INC | $5,814,163 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
| 10 | COMPASS FINANCIAL MANAGEMENT LLC | $5,274,931 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:44 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
DOL H-1B (LCA) · WARN NOT HELD12. Labor
| Measure | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| Employer name (as filed) | ClearPoint Neuro, Inc. | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
| Certified LCAs | 1 | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
| Certified LCAs later withdrawn | 0 | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
| Total worker positions on certified LCAs | 1 | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
| Top job titles (title, LCA count) | Senior Scientist (1) | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
| Wage offered, annualized (n, min, median, max) | median $122,000 (range $122,000-$122,000, 1 filings) | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
| Worksite states | CA | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-21 00:44 UTC | Report an error |
Unconfirmed: these labor figures (positions, worksite states, certified LCAs later withdrawn) are as read from DOL's quarterly LCA disclosure file. Seraphix's independent second check of them is not finished (11-19); they are shown as filed, not as verified.
WARN layoff notices: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
2 state and city records carry this company's exact name, from 1 source. Possible matches only.
USAspending (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchCLEARPOINT NEURO, INC. · exact legal name · sx:usaspending:D777WG1K5PL4 Compare
- possible matchCLEARPOINT NEURO, INC. · exact legal name · sx:usaspending:YRFSE7QUB6Q7 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1285550.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001285550. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.